This exciting opportunity builds on our previous 3 years work and allows us to play a crucial role in advancing the field of biomedical research through innovative technology. The Biomedical Data Translator program aims to address a critical challenge in modern scientific research: connecting the right data with the right questions in an era of information abundance. By developing an intuitive and powerful user interface, we will help researchers more easily identify connections across diverse datasets, ultimately accelerating the discovery of new treatments and improving patient outcomes.
Our team at BMA is set to improve and expand upon the capabilities of the recently released Biomedical Data Translator System UI. Leveraging our expertise in enterprise-level software engineering and data science research, we will create a user-friendly interface that bridges the gap between biomedical researchers and the vast, integrated knowledge base of the Translator system. This interface will serve as a vital resource for computationally assisted exploration of knowledge and the construction of new research hypotheses, augmenting human reasoning and inference in understanding the pathophysiology of human diseases.
The Translator program has entered its critical Development phase, and our work on the user interface is paramount to ensuring that the core system meets the needs of its users. We are building upon the foundational work of knowledge graph standards, data transformation mechanisms, and advanced reasoning capabilities established during the program's three-year feasibility assessment phase, which concluded in January 2020. Our goal is to make these technological achievements not only visible but also accessible and practical for everyday use in the biomedical research community.
BMA brings a wealth of experience and a unique perspective to this project. Headquartered in Huntsville, AL, we operate in 27 states and have a presence in U.S. CENTCOM, U.S. EUCOM, U.S. INDOPACOM, and U.S. SOUTHCOM. We take pride in our workforce, with over 70% of our employees being Veterans and more than 40% Service-Disabled Veterans. This diverse background allows us to approach challenges with creativity and determination. We are eager to continue our work for the NIH and contribute to this groundbreaking initiative that has the potential to transform biomedical research and, ultimately, improve human health on a global scale.